Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Emily D. Parker, PhD, MPH
Advertisement
Articles by Emily D. Parker, PhD, MPH
Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
Physician practices account for a significant amount of variation in spending.
Advertisement
Latest Updated Articles
- Variation in Spending Associated With Primary Care Practices
Published: December 15th 2020 | Updated:
- Costs for Commercially Insured Adults Prescribed Second-line Diabetes Medications
Published: March 9th 2021 | Updated:
Treatment Modification After Initiating Second-Line Medication for Type 2 DiabetesPublished: December 12th 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
How Can Trauma Affect the Menopausal Transition?
4
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
5
